Literature DB >> 7366341

The specific activity of retained and released norepinephrine in dog saphenous vein prelabeled with radiolabeled norepinephrine.

D K Rorie, S M Muldoon, G M Tyce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7366341     DOI： 10.1016/0024-3205(80)90260-x

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  8 in total

1.  Cocaine and neuronal uptake in the canine saphenous vein.

Authors:  T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

2.  Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.

Authors:  E Müller-Schweinitzer
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

3.  Role of auto-inhibitory feed-back in cardiac sympathetic transmission assessed by simultaneous measurements of changes in 3H-efflux and atrial rate in guinea-pig atrium.

Authors:  J A Angus; A Bobik; G P Jackman; I J Kopin; P I Korner
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

4.  Moderate cooling depresses the accumulation and the release of newly synthesized catecholamines in isolated canine saphenous veins.

Authors:  P J Boels; T J Verbeuren; P M Vanhoutte
Journal:  Experientia       Date:  1985-11-15

5.  Actions of co-dergocrine mesylate and its components at vascular smooth muscle.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

6.  Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.

Authors:  G Engel; M Göthert; E Müller-Schweinitzer; E Schlicker; L Sistonen; P A Stadler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

7.  Differences between the neuronal handling of 3H-7- and 3H-7,8-(-)noradrenaline: implications for the release of the labelled neurotransmitter by nerve stimulation.

Authors:  M Henseling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

8.  Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.